SEC Form D private-offering filing

Medicenna Therapeutics Corp.

Name: Medicenna Therapeutics Corp. - new SEC Form D private-offering filing, Toronto, ON, Canada
Published: 2026-07-06

A new SEC Form D private-offering notice from Toronto, ON, Canada, a $2,343,400 filer-stated offering target in Biotech. The source filing is one click away.

Medicenna Therapeutics Corp. site↗ Verified via SEC Form D

Clinical-stage immuno-oncology biotech developing engineered interleukin based cytokine therapies (Superkine, BiSKIT platforms) for cancer, publicly traded on NASDAQ/TSX as MDNA.

Filed 2026-07-06Filed to raise $2,343,400First money in 2026-05-28Raised so far $253,458HQ (as filed) Toronto, ON, CanadaSector Biotech ✓Stage (inferred) SeedCall status Needs classification

Source linked the Form D on EDGAR↗Website verified medicenna.com↗Named in the filing 9 executives & directors

Open this row on the live feed →More Biotech filings →

This is a public SEC Form D private-offering notice, the filer's own statement to the SEC. Amounts are offering targets, not confirmed closes. Takeoff Radar pulls Form D nightly from EDGAR and links every filing to its source.